Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2005
11/22/2005US6967245 Ucp5
11/22/2005US6967089 Delivery system for porcine somatotropin
11/22/2005US6967076 A reporter sequence consists of a reporter gene whose expression is regulated by a protein specific to HIV viruses, expressed from a genome of an HIV virus upon infection of a cell tranduced by genetic engineered viral vector
11/22/2005US6967018 Adiponectin gene therapy
11/17/2005WO2005109002A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005109001A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005109000A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005108949A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005108607A1 Compositions and methods for treating disorders associated with abnormal phosphate metabolism
11/17/2005WO2005108584A1 Recombinant chemokine-antigen vaccine
11/17/2005WO2005108581A1 Recombinant virus vector for gene introduction in lymphocyte
11/17/2005WO2005108575A1 T-type calcium channel splice variant compositions and methods
11/17/2005WO2005108572A1 Compounds and method for immunosuppression
11/17/2005WO2005108570A1 Nucleic acid/enzyme complex
11/17/2005WO2005107817A2 Medical device with coating for capturing genetically-altered cells and methods of using same
11/17/2005WO2005107816A2 Methods and compositions for reducing viral genome amounts in a target cell
11/17/2005WO2005107790A1 Hybrid recombinases for genome manipulation
11/17/2005WO2005077423A3 Adept or gdept producing acetaldehyde
11/17/2005WO2005046622A3 Custom vectors for treating and preventing pancreatic cancer
11/17/2005WO2005039643A3 In vivo gene therapy of parkinson's disease
11/17/2005WO2005030122A3 Inactivated host cell delivery of polynucleotides encoding immunogens
11/17/2005WO2005026331A3 Method of preparation of pharmaceutically grade plasmid dna
11/17/2005WO2005023311A3 Novel targets for the treatment of retina diseases
11/17/2005WO2004108945A3 Oligonucleotide modulation of cell adhesion
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005WO2004024087A3 Methods of diagnosing and treating hyperproliferative disorders
11/17/2005WO2001065911A9 Improved poloxamer and poloxamine compositions for nucleic acid delivery
11/17/2005US20050257276 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/17/2005US20050256525 Dilation introducer for orthopedic surgery
11/17/2005US20050256077 Gastrointestinal stem cells and uses thereof
11/17/2005US20050256076 RNA interference modulators of hedgehog signaling and uses thereof
11/17/2005US20050256075 Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
11/17/2005US20050256074 Methods and compositions for regulating lymphocyte activity
11/17/2005US20050256073 Immunostimulatory viral RNA oligonucleotides
11/17/2005US20050256072 Dual functional oligonucleotides for use in repressing mutant gene expression
11/17/2005US20050256071 Inhibitor nucleic acids
11/17/2005US20050256069 IRNA agents with biocleavable tethers
11/17/2005US20050256068 Moderator of gene expression; using small nucleic acids
11/17/2005US20050256067 Method of preparing a treatment product, treatment product and a plasmid construct
11/17/2005US20050256052 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes
11/17/2005US20050256051 Nuclear receptor-mediated introduction of a PNA into cell nuclei
11/17/2005US20050256050 Vascular endothelial growth factor 2
11/17/2005US20050256044 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050256036 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/17/2005US20050255597 Transformation of cells with vector carrying transgenic virus
11/17/2005US20050255588 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
11/17/2005US20050255550 Suppression of xenotransplant rejection
11/17/2005US20050255543 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration
11/17/2005US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/17/2005US20050255518 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
11/17/2005US20050255487 Methods and compositions for selecting siRNA of improved functionality
11/17/2005US20050255162 Hydrophobic biomolecular structure
11/17/2005US20050255153 Mixture of deprotonatable lipid, such as polyoxyethylene glycol or polyamide lipid with buffered aqueous solution of charged drug
11/17/2005US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
11/17/2005US20050255124 HCV E1E2 vaccine compositions
11/17/2005US20050255123 Chimeric ebola virus envelopes and uses therefor
11/17/2005US20050255113 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
11/17/2005US20050255111 Use of an inhibitor or antagonist against tissue factor
11/17/2005US20050255100 Isolated nucleic acid encoding a human polypeptide, tumor necrosis factor receptor-5; tumor necrosis factor blocking agent; cyclosporine immunosuppressant; antibiotic; anti-inflammatory; graft versus host disease, viral infection, cancer, leukemia, immunodeficiency, autoimmune disorder
11/17/2005US20050255095 Destruction of prions using vibrolysin or variants thereof
11/17/2005US20050255093 treating nervous system disorders induced by stroke or injury, injured by trauma to reduce oxidative stress, administering a conjugate of antioxidant enzyme and a clostridial neurotoxin cell binding domain, and a clostridial neurotoxin translocation domain; tissue-targeted therapy
11/17/2005US20050255088 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer
11/17/2005US20050255087 Adeno-associated virus vectors
11/17/2005US20050255086 Adeno-associated viral vector comprising short interfering RNA for use in the treatment of nervous system disorders; tissue engineering and gene therapy; tissue targeted therapy
11/17/2005US20050255085 Prevention of recurrence and metastasis of cancer
11/17/2005US20050255084 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
11/17/2005US20050255039 Gel injection treatment of breast, fibroids & endometrial ablation
11/17/2005CA2566041A1 T-type calcium channel splice variant compositions and methods
11/17/2005CA2565509A1 Recombinant virus vector for gene introduction in lymphocyte
11/17/2005CA2564503A1 Methods and compositions for reducing viral genome amounts in a target cell
11/17/2005CA2563329A1 Medical device with coating for capturing genetically-altered cells and methods of using same
11/17/2005CA2562552A1 Hybrid recombinases for genome manipulation
11/16/2005EP1595954A1 Human papilloma virus inhibition by antisense oligonucleotides
11/16/2005EP1595548A2 Anti-neovasculature preparations for treating cancer
11/16/2005EP1595145A2 Methods for the treatment of renal cell carcinoma
11/16/2005EP1595142A2 Method for evaluating the efficacy of certain cancer treatments
11/16/2005EP1595129A2 Methods of identifying modulators of cellular glycosylation using gtrap3-18
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594988A2 Method of diagnosis of type 2 diabetes and early onset thereof
11/16/2005EP1594977A2 Reversible attachment of a membrane active polymer to a polynucleotide
11/16/2005EP1594964A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor
11/16/2005EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide
11/16/2005EP1594552A2 Topical delivery of cosmetic agents
11/16/2005EP1594549A2 Hypoxia inducible vegf plasmid for ischemic disease
11/16/2005EP1594527A2 Vegf-b and pdgf modulation of stem cells
11/16/2005EP1594514A2 Combination therapy for treating protein deficiencies
11/16/2005EP1594439A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
11/16/2005EP1594437A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
11/16/2005EP1594433A2 Cancer therapy sensitizer
11/16/2005EP1594432A2 Short immunomodulatory oligonucleotides
11/16/2005EP1498129B1 Use of adenoviruses mutated in the va genes for cancer treatment
11/16/2005EP1319082B1 Expression vectors containing hybrid ubiquitin promoters
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005EP1082423B1 Cyclin e2 genes and proteins
11/16/2005EP1068328B1 Treatment and diagnosis of staphylococcal infections
11/16/2005EP1019493B1 Generation of hematopoietic cells from multipotent neural stem cells
11/16/2005CN1697879A Biomolecule transfer method using virus envelope and composition and system therefor
11/16/2005CN1696293A Gene recombined chemotaxis antigen vaccine
11/16/2005CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 870